Use of sphingosine as inhibitor of protein kinase C.
Hannun
Y A
YA
Merrill
A H
AH
Bell
R M
RM
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D004075:Diglycerides / Q000378:metabolism / Q000494:pharmacology; D004789:Enzyme Activation; D007546:Isoquinolines / Q000494:pharmacology; D007700:Kinetics; D015240:Phorbol 12,13-Dibutyrate / Q000378:metabolism; D010703:Phorbol Esters / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013110:Sphingosine / Q000378:metabolism / Q000494:pharmacology*
D004075:Diglycerides; D007546:Isoquinolines; D010703:Phorbol Esters; D010879:Piperazines; D015240:Phorbol 12,13-Dibutyrate; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D011493:Protein Kinase C; D013110:Sphingosine